Article Information
History
- November 23, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Eva Camarillo-Retamosa1,2,*,
- Luke Watson1,2,
- Paul Loftus1,3,
- Senthil Alagesan1,
- Yvonne O’Donoghue1,
- Laura M. Deedigan1,
- Lisa O’Flynn4,
- Laura R. Barkley3 and
- Stephen J.Elliman1,*
- 1Orbsen Therapeutics Ltd., Galway, Ireland
- 2School of Medicine, College of Medicine, Nursing and Health Sciences, National University of Ireland, Galway, Ireland
- 3Lambe Institute for Translational Research, National University of Ireland Galway, Ireland
- 4Avectas Ltd, Maynooth University, Co. Kildare, Ireland
- ↵*To whom correspondence should be addressed. Stephen J. Elliman steve.elliman{at}orbsentherapeutics.com Correspondence may also be addressed to Eva Camarillo-Retamosa eva.camarillo.retmosa{at}gmail.com